A surge in mergers and acquisitions is having a profound impact on the pharmaceutical and medical device industries. U.S. firms are seeking lower taxes abroad, and some deals include foreign moves. Treasury Secretary Jack Lew has written to Congress urging retroactive adoption of tax changes that would discourage such deals, known as tax inversion.

Related Summaries